UP FRONT
ASH Directions
Congratulations to the 2018 Trainee
Abstract Award Winners
ASH is pleased to announce the recipients of the 2018 Outstanding
Abstract Achievement Award, who will be recognized for their ac-
complishments at the ASH Annual Meeting in San Diego. The award
recognizes the highest-scoring abstracts in the categories of undergrad-
uate student, medical student, graduate student, resident physician, and
postdoctoral fellow.
“I commend these early-career researchers on their high-quality
work and contributions to hematology,” said ASH President Alexis A.
Thompson, MD, MPH. “Presenting on a stage as large and visible as
the ASH annual meeting is an important career milestone. The recipi-
ents of these awards should feel very proud of their achievement.”
The following trainees will be recognized:
Undergraduate Student
Jesus Garcia Garcia
University of Minnesota, Minneapolis, MN
5 Year Health Care Burden after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT):
Impact of Graft Source
Medical Student
Attendees browse the poster abstracts at the ASH annual meeting.
Rosalie Sterner
Mayo Clinic, Rochester, MN
GM-CSF Blockade during Chimeric Antigen Receptor T Cell Therapy Reduces Cytokine Release
Syndrome and Neurotoxicity and May Enhance Their Effector Functions
Graduate Student
Sickle Cell Disease Clinical Trials
Network Now Accepting Applications
The American Society of Hematology recently established the ASH Research Collabora-
tive (ASH RC), a separate nonprofit organization dedicated to fostering collaborative
partnerships to accelerate progress in hematology, with the goal of improving the lives
of people affected by blood diseases. The first research initiative of the ARC, a Sickle
Cell Disease (SCD) Clinical Trials Network (CTN) that aims to optimize the conduct of
clinical trials research in SCD and improve the lives of people affected by the disease, is
seeking clinical research sites at institutions interested in joining the Network.
The SCD CTN will promote quality, patient safety, and efficiency in SCD clinical
trials by centralizing functions and sharing best practices. Trial sites will work with the
Network to increase patient
understanding of clinical tri-
als and trust in SCD research-
ers, eliminate inefficiencies
through the centralized ASH
RC Data Hub and institu-
tional review board, and focus
on the research opportunities
that hold the most promise.
While traditional respon-
sibilities for running a clinical trial will remain with the participating sites and industry,
the SCD CTN will address many of the common barriers faced in clinical trials research,
including patient engagement and recruitment, site and sponsor matching, and research
coordination.
The ASH RC will host a Q&A Reception about the SCD CTN in Room 2 of the San
Diego Convention Center from 6:00 p.m. to 7:30 p.m. on December 3, during the ASH
annual meeting. Representatives of prospective research sites are invited to attend the
session, where they will have a chance to have their questions answered directly by
ASH RC leadership.
Letters of Intent to join the SCD CTN will be accepted through January 31, 2019.
Please visit ashresearchcollaborative.org for more information about the ASH RC and
to download the request for proposals.
18
ASH Clinical News
Camila Prieto
Memorial Sloan Kettering Cancer Center, New York, NY
RNA Binding Protein RBMX Is Required in Acute Myeloid Leukemia by Regulating the
Transcriptional Activity of the Heterochromatin Protein HP1α
Resident Physician
Philipp Rauch, MD
Boston University School of Medicine, Boston, MA
Loss-of-Function Mutations in Dnmt3a and Tet2 Lead to Accelerated Atherosclerosis and
Convergent Macrophage Phenotypes in Mice
Post-Doctoral Fellow
Jun Chen, MD, PhD
Lund University, Lund, Sweden
Small Molecule Screens Identify CDK8-Inhibitors as Candidate Diamond-Blackfan Anemia
Drugs
Mary Rodes Gibson Memorial Award in
Hemostasis and Thrombosis
This award was established to recognize the trainee who is the first author and presenter of
the highest-scoring abstract submitted to the ASH annual meeting in the field of hemostasis
and thrombosis.
Moua Yang, PhD
Medical College of Wisconsin, Milwaukee, WI
Platelet CD36 Promotes ERK5 and Caspase-Dependent Procoagulant Phosphatidylserine
Externalization and In Vivo Fibrin Formation in Dyslipidemia
Please visit hematology.org/Awards to learn how ASH supports hematologists in all
stages of their careers.
December 2018